Toxin chimeras slip therapeutics into neurons to treat botulism in animals

January 06, 2021

Taking advantage of the chemical properties of botulism toxins, two teams of researchers have fashioned non-toxic versions of these compounds that can deliver therapeutic antibodies to treat botulism, a potentially fatal disease with few approved treatments. The research, which was conducted in mice, guinea pigs, and nonhuman primates, suggests that the toxin derivatives could one day offer a platform to quickly treat established cases of botulism and target hard-to-reach molecules within neurons. Botulism manifests due to bacterial toxins called botulinum neurotoxins (BoNTs), which are the most potent toxins known to humans. BoNTs work by entering and damaging neurons that coordinate movement, resulting in paralysis that requires intensive care and can potentially last for months. There is a dire need for therapies that can quickly reverse paralysis, but developing treatments for existing cases has been difficult because it is challenging to neutralize BoNTs with therapeutics once the toxins have entered neurons. In the first study, Shin-Ichiro Miyashita and colleagues fused different sections of two BoNTs named BoNT/X and BoNT/A, resulting in a chimeric molecule that is both non-toxic and works as a drug delivery platform. Specifically, the researchers combined a neuron-targeting domain of BoNT/A with another domain of BoNT/X that can deliver therapeutic molecules into the interior of neurons. Miyashita et al. found that their approach rapidly delivered an antitoxin antibody into neurons and neutralized both the BoNT/A and BoNT/B neurotoxins in mice, reversing paralysis within a few hours. Taking a similar approach, Patrick McNutt and colleagues engineered a non-toxic BoNT derivative that safely neutralized BoNT/A within neurons. Their treatment also alleviated paralysis and boosted survival in mice, guinea pigs, and nonhuman primates exposed to lethal amounts of BoNT/A. "This platform offers a transformational approach for a precision treatment that might be adapted to diverse presynaptic diseases," say McNutt et al.
-end-


American Association for the Advancement of Science

Related Neurons Articles from Brightsurf:

Paying attention to the neurons behind our alertness
The neurons of layer 6 - the deepest layer of the cortex - were examined by researchers from the Okinawa Institute of Science and Technology Graduate University to uncover how they react to sensory stimulation in different behavioral states.

Trying to listen to the signal from neurons
Toyohashi University of Technology has developed a coaxial cable-inspired needle-electrode.

A mechanical way to stimulate neurons
Magnetic nanodiscs can be activated by an external magnetic field, providing a research tool for studying neural responses.

Extraordinary regeneration of neurons in zebrafish
Biologists from the University of Bayreuth have discovered a uniquely rapid form of regeneration in injured neurons and their function in the central nervous system of zebrafish.

Dopamine neurons mull over your options
Researchers at the University of Tsukuba have found that dopamine neurons in the brain can represent the decision-making process when making economic choices.

Neurons thrive even when malnourished
When animal, insect or human embryos grow in a malnourished environment, their developing nervous systems get first pick of any available nutrients so that new neurons can be made.

The first 3D map of the heart's neurons
An interdisciplinary research team establishes a new technological pipeline to build a 3D map of the neurons in the heart, revealing foundational insight into their role in heart attacks and other cardiac conditions.

Mapping the neurons of the rat heart in 3D
A team of researchers has developed a virtual 3D heart, digitally showcasing the heart's unique network of neurons for the first time.

How to put neurons into cages
Football-shaped microscale cages have been created using special laser technologies.

A molecule that directs neurons
A research team coordinated by the University of Trento studied a mass of brain cells, the habenula, linked to disorders like autism, schizophrenia and depression.

Read More: Neurons News and Neurons Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.